As of June 30, 2025, Eden Research plc. carries a market capitalization of 20.54M, placing it among publicly traded companies globally. Its enterprise value stands at 18.84M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 20.54M |
| Enterprise Value | 18.84M |
Eden Research plc.'s next confirmed earnings release is scheduled for December 16, 2026.
| Earnings Date | 12/16/2026 |
As of June 30, 2025, Eden Research plc. has 533.35M shares outstanding.
| Shares Outstanding | 533.35M |
These figures are as of June 30, 2025.
| PB Ratio | 1.41 |
| P/TBV Ratio | 4.61 |
As of June 30, 2025, Eden Research plc. maintains a current ratio of 2.17, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.17 |
| Quick Ratio | 0.77 |
| Debt / Equity | 5.39 |
As of the close on November 3, 2026, Eden Research plc.'s stock has gained approximately 42.57% over the past 52 weeks.
| 52-Week Price Change | 42.57% |
As of June 30, 2025, Eden Research plc. holds 2.53M in cash and equivalents against 785,136.47 in total debt, resulting in a net debt position of -2.53M. Total book value stands at 14.52M, with working capital of 3.87M providing operational flexibility.
| Cash & Cash Equivalents | 2.53M |
| Total Debt | 785,136.47 |
| Net Debt | -2.53M |
| Equity (Book Value) | 14.52M |
| Book Value Per Share | 0.03 |
| Working Capital | 3.87M |
Eden Research plc.'s most recent stock split took place on March 2, 2020.
| Last Split Date | 3/2/2020 |
Already premium?